Wednesday, June 15, 2016

New in LexiComp


Wolters Kluwer
Clinical Drug Information
 
 
 
Lexicomp Online Updates
 
■ 
ENHANCED: Drug Comparisons Tool
■ 
NEW: Toxicology Field in Core Drug Monographs
■ 
ENHANCED: Direct Access to Formulary Monograph Service (FMS)
 
ENHANCED: Drug Comparisons Tool
 
Now you can find your Drug Comparisons module on the blue toolbar under its own “Drug Comparisons” heading, rather than under the previous “Facts & Comparisons” button. The module also now opens directly within your Lexicomp Online interface for a streamlined look and feel.
 
Clicking Drug Comparisons provides two drop-down options for viewing comparative tables:
 
■ 
Data View – compare up to four drugs in a table format
■ 
Monograph View – compare up to four drugs as side-by-side monographs
 
For more on how to use the Drug Comparisons Tool, watch this short training video.
 
 

NEW: Toxicology Field in Core Drug Monographs
 
Find toxicology information within core drug monographs in the Lexi-Drugs, Pediatric & Neonatal Lexi-Drugs, and Multinational drug databases.
 
Previously, toxicology content was only accessible through the Toxicology module. To improve ease of use and access to the information, we added summary toxicology content under the Adverse Reactions section of relevant drug monographs. Users can then click through to the more in-depth Agent of Toxicity monograph without interrupting workflow.
 
ENHANCED: Easier Access to Formulary Monograph Service (FMS)
 
Subscribers to the Formulary Monograph Service add-on module will now see a dedicated "Formulary Monograph Service" button on the blue toolbar atop every page of Lexicomp Online. This link will connect subscribers directly to the module, which features detailed information about recently released and investigational drugs.
 
 
 
Wolters Kluwer Health
 
 
 
 
Wolters Kluwer Clinical Drug Information | 1100 Terex Rd. Hudson, Ohio 44236
Phone: (855) 633-0577 | International: +1 (330) 650-6506

 Support | Contact Us | Privacy Policy |
© 2016 Wolters Kluwer Clinical Drug Information, Inc. and its affiliates and/or licensors. All rights reserved.
 

No comments:

Post a Comment